Duloxetine for Depression

"This study is not presently recruiting candidates at this time. The trial was initially posted on 11/1/2021 and was most recently edited on 4/21/2021. If you are searching for other studies, 865 clinical trials for melancholia and 26 trials for Duloxetine are actively recruiting participants ."

"This study requires 80 individuals who suffer from melancholia and fit the following age, medication, and handedness criteria: 18 - 55 years old; no new treatments during the clinical trial; unmedicated for at least 10 half-lives of the previous AD used; right handed."

"Duloxetine, an investigational medication, is being trialled in 26 different studies. 4 of these are large-scale Phase 3 trials. Not limited to Redwood City, California, there are 786 hospitals and medical facilities conducting clinical trials for Duloxetine across the world."

"Duloxetine has received a safety score of 3. This is because it is a Phase 3 medication, suggesting that not only is there some evidence for its efficacy, but also that there are multiple rounds of data supporting its safety."

"Duloxetine can be used as an intervention for patients experiencing diabetic peripheral neuropathy, major depressive disorder, and pain in the knee."

"This particular clinical trial only enrolls patients that are between 18-55 years old. In contrast, there are 113 trials for minors and 633 for senior citizens."

"This trial is not recruiting at the moment. The listing was created on November 1st, 2021 and last updated on April 21st, 2021. For patients looking for similar studies, there are 865 trials actively enrolling participants with melancholia and 26 trials for Duloxetine currently searching for candidates."